Status | Study |
Not yet recruiting |
Study Name: Pediatric MATCH: Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Advanced Refractory Solid Tumors or Lymphomas Condition: Histiocytic Sarcoma Juvenile Xanthogranuloma Date: 2017-05-15 Interventions: Drug: ALK Inhibitor X-396 Give |
Recruiting |
Study Name: A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis Condition: Histiocytosis Date: 2017-04-11 Interventions: Behavioral: Trail Making Test, Parts A & B |
Recruiting |
Study Name: Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement Condition: Erdheim-Chester Disease Langerhans Cell Histiocytosis Date: 2015-11-17 Interventions: Radiation: F-choline PET Scan Device: FDG- |
Recruiting |
Study Name: A Study of Lenalidomide for Adult Histiocyte Disorders Condition: Langerhans Cell Histiocytosis (LCH) Histiocytoses Erdheim-chester Dise Date: 2015-08-12 Interventions: Drug: Lenalidomide Other Name: Revlimid |
Recruiting |
Study Name: International Rare Histiocytic Disorders Registry (IRHDR) Condition: Rare Histiocytic Disorders (RHDs) Juvenile Xanthogranuloma (JXG Date: 2014-11-03 Interventions: Other: Registry study No intervention. |
Suspended |
Study Name: Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease Condition: BRAF V600E Mutation Date: 2014-11-01 Interventions: Drug: Dabrafenib Mesylate Desc |
Recruiting |
Study Name: Biomarker for Farber Disease Condition: Farber's Lipogranulomatosis Ceramidase Deficiency Date: 2014-10-23 |
Recruiting |
Study Name: Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease Condition: Erdheim-Chester Disease Date: 2014-03-15 |
Terminated |
Study Name: Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease Condition: Erdheim-Chester Disease Date: 2012-11-12 Interventions: Drug: Tocilizumab Other Names: Ro-Actemra Actemra |
Recruiting |
Study Name: Clinical and Basic Investigations Into Erdheim Chester Disease Condition: Myelofibrosis Gaucher Disease Pulmonary Fibrosis Date: 2011-08-13 |